These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 21601209)

  • 1. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models.
    Kleemann R; Verschuren L; Morrison M; Zadelaar S; van Erk MJ; Wielinga PY; Kooistra T
    Atherosclerosis; 2011 Sep; 218(1):44-52. PubMed ID: 21601209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epicatechin attenuates atherosclerosis and exerts anti-inflammatory effects on diet-induced human-CRP and NFκB in vivo.
    Morrison M; van der Heijden R; Heeringa P; Kaijzel E; Verschuren L; Blomhoff R; Kooistra T; Kleemann R
    Atherosclerosis; 2014 Mar; 233(1):149-56. PubMed ID: 24529136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction.
    Loke WM; Proudfoot JM; Hodgson JM; McKinley AJ; Hime N; Magat M; Stocker R; Croft KD
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):749-57. PubMed ID: 20093625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.
    Yoshii T; Iwai M; Li Z; Chen R; Ide A; Fukunaga S; Oshita A; Mogi M; Higaki J; Horiuchi M
    Hypertens Res; 2006 Jun; 29(6):457-66. PubMed ID: 16940709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory salicylate beneficially modulates pre-existing atherosclerosis through quenching of NF-κB activity and lowering of cholesterol.
    de Vries-van der Weij J; Toet K; Zadelaar S; Wielinga PY; Kleemann R; Rensen PC; Kooistra T
    Atherosclerosis; 2010 Nov; 213(1):241-6. PubMed ID: 20926077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice.
    Ortiz MA; Campana GL; Woods JR; Boguslawski G; Sosa MJ; Walker CL; Labarrere CA
    Exp Biol Med (Maywood); 2009 Jun; 234(6):624-31. PubMed ID: 19359657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dietary mixture containing fish oil, resveratrol, lycopene, catechins, and vitamins E and C reduces atherosclerosis in transgenic mice.
    Verschuren L; Wielinga PY; van Duyvenvoorde W; Tijani S; Toet K; van Ommen B; Kooistra T; Kleemann R
    J Nutr; 2011 May; 141(5):863-9. PubMed ID: 21411607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells.
    Tribolo S; Lodi F; Connor C; Suri S; Wilson VG; Taylor MA; Needs PW; Kroon PA; Hughes DA
    Atherosclerosis; 2008 Mar; 197(1):50-6. PubMed ID: 17880982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of kaempferol and quercetin on cytokine-induced pro-inflammatory status of cultured human endothelial cells.
    Crespo I; García-Mediavilla MV; Gutiérrez B; Sánchez-Campos S; Tuñón MJ; González-Gallego J
    Br J Nutr; 2008 Nov; 100(5):968-76. PubMed ID: 18394220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenofibrate reduces atherogenesis in ApoE*3Leiden mice: evidence for multiple antiatherogenic effects besides lowering plasma cholesterol.
    Kooistra T; Verschuren L; de Vries-van der Weij J; Koenig W; Toet K; Princen HM; Kleemann R
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2322-30. PubMed ID: 16873727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual PPARalpha/gamma agonist tesaglitazar reduces atherosclerosis in insulin-resistant and hypercholesterolemic ApoE*3Leiden mice.
    Zadelaar AS; Boesten LS; Jukema JW; van Vlijmen BJ; Kooistra T; Emeis JJ; Lundholm E; Camejo G; Havekes LM
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2560-6. PubMed ID: 16931788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of VCAM-1 antibodies as therapeutic agent for atherosclerosis in apolipoprotein E-deficient mice.
    Park JG; Ryu SY; Jung IH; Lee YH; Kang KJ; Lee MR; Lee MN; Sonn SK; Lee JH; Lee H; Oh GT; Moon K; Shim H
    Atherosclerosis; 2013 Feb; 226(2):356-63. PubMed ID: 23245509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.
    Hirschfield GM; Gallimore JR; Kahan MC; Hutchinson WL; Sabin CA; Benson GM; Dhillon AP; Tennent GA; Pepys MB
    Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8309-14. PubMed ID: 15919817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis.
    Nachtigal P; Pospisilova N; Pospechova K; Jamborova G; Kopecky M; Jaynes R; Briestensky J; Santar I; Smahelova A; Solichova D; Zdansky P; Semecky V
    Life Sci; 2006 Mar; 78(17):1983-9. PubMed ID: 16305803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proatherogenic macrophage activities are targeted by the flavonoid quercetin.
    Lara-Guzman OJ; Tabares-Guevara JH; Leon-Varela YM; Álvarez RM; Roldan M; Sierra JA; Londoño-Londoño JA; Ramirez-Pineda JR
    J Pharmacol Exp Ther; 2012 Nov; 343(2):296-306. PubMed ID: 22869926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of uremia in apolipoprotein E-deficient mice.
    Bro S
    Dan Med Bull; 2009 Nov; 56(4):177-92. PubMed ID: 19939336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosuvastatin can block pro-inflammatory actions of transgenic human C-reactive protein without reducing its circulating levels.
    Šilhavý J; Zídek V; Landa V; Šimáková M; Mlejnek P; Škop V; Oliyarnyk O; Kazdová L; Mancini M; Saar K; Schulz H; Hübner N; Kurtz TW; Pravenec M
    Cardiovasc Ther; 2014 Apr; 32(2):59-65. PubMed ID: 24410968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules.
    Tikellis C; Jandeleit-Dahm KA; Sheehy K; Murphy A; Chin-Dusting J; Kling D; Sebokova E; Cooper ME; Mizrahi J; Woollard KJ
    Atherosclerosis; 2008 Jul; 199(1):55-64. PubMed ID: 18093596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursolic acid suppresses IL-6 induced C-reactive protein expression in HepG2 and protects HUVECs from injury induced by CRP.
    Lv YY; Jin Y; Han GZ; Liu YX; Wu T; Liu P; Zhou Q; Liu KX; Sun HJ
    Eur J Pharm Sci; 2012 Jan; 45(1-2):190-4. PubMed ID: 22108347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.